FDA puts muscle in food code regulations
- Feeling Secure. Gallo-Torres, Julia M. // Prepared Foods;Jun2007, Vol. 176 Issue 6, p7
The author reflects on food safety issues in the U.S. The U.S. Food and Drug Administration has asked the Congress for additional funds to enhance its ability to monitor the safety of food. The agency also wants to put more stringent rules on produce growers in order to decrease the incidence of...
- Ban the Bromate. // Nutrition Action Health Letter;Oct99, Vol. 26 Issue 8, p2
Focuses on the efforts of the United States Food and Drug Administration to ban bromate in baked goods. Adverse effects of potassium bromate; Brands that still use potassium bromate.
- Bill seeks to bring FDA's blurry lines into focus. Wechsler, Jill // Managed Healthcare;Dec97, Vol. 7 Issue 12, p22
Focuses on the legislation that clarifies the United States Food and Drug Administration regulations. Allowing of pharmaceutical companies to disseminate competent healthcare economic information to sophisticated purchasers; Allowing of drugmakers to distribute peer-reviewed journal articles...
- New molecular entities. // Formulary;Sep97, Vol. 32 Issue 9, p881
Presents several drugs approved by the US Food and Drug Administration. Sodium capsules for the management of pain; Tablets for the treatment of advanced breast cancer; Dopamine agonist for the treatment of Parkinson's disease.
- FDA issues reprint guidelines. // Dermatology Times;Jan1996, Vol. 17 Issue 1, p68
Reports that the Food and Drug Administration will be issuing guidelines, permitting distribution of journal reprints studies, that support an approved indication, but make reference to unapproved uses. What companies will be allowed to distribute; Guidelines concerning IND submission.
- FDA Safety Page. Holquist, Carol // Patient Care;1/15/2002, Vol. 36 Issue 1, p54
Focuses on the drug name review process created by the U.S. Food and Drug Administration in January 2002. Handwriting and verbal analyses; Computer assisted analysis; Evaluation of risks.
- Paranoid annoyance. Schwartz, Harry // Pharmaceutical Executive;Sep98, Vol. 18 Issue 9, p24
Focuses on the withdrawal of several pharmaceutical products in the United States market due to their adverse effects on human body. Political aspects of the problem; Reason behind Food and Administration's (FDA) approval of propulsid and sildenafil; Possible effects of the move of FDA.
- Consumer groups blast FDA reform legislation. // Health Facilities Management;Sep97, Vol. 10 Issue 9, p10
Focuses on the legislation aimed at reforming the US Food and Drug Administration, led by retired Senator Howard Metzenbaum. Bill that was approved by the Senate Labor and Human Resources Committee; One of the provisions that is troubling Metzenbaum.
- Close call. Conlan, Michael F. // Drug Topics;12/8/97, Vol. 141 Issue 23, p101
Looks at United States Food and Drug Administration (FDA), reform on the protection legislation for pharmacies, with reference to House and Senate conferees. Limits of the FDA authority; Importance of federal law; Information FDA reform package.